Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, with an
estimated rising prevalence, in concert with the epidemics of obesity and type 2 diabetes …

Abstract Classically, Non-Alcoholic Fatty Liver Disease (NAFLD) has been thought to be
driven by excessive weight gain and obesity. The overall greater awareness of this disorder …

Metabolic associated fatty liver disease (MAFLD) is the principal worldwide cause of liver
disease and affects nearly a quarter of the global population. The objective of this work was …

Objectives The burden of nonalcoholic fatty liver disease (NAFLD) is increasing, with an
estimated prevalence in Europe of 20–30%. Although most patients present with simple …

The map and global disease burden of chronic liver diseases are markedly changing, with
nonalcoholic fatty liver disease (NAFLD) becoming the most common cause of liver …

Methods A total of 560 patients (28 lean, 174 overweight, 229 obese, 89 severely obese, 40
morbidly obese) were included. Diagnostic performances and optimal cut-off values for FIB …

Background In patients with nonalcoholic fatty liver disease, liver fibrosis was associated
with a higher risk of cardiovascular events. However, the relationship between liver fibrosis …

The landscape of chronic liver disease in Egypt has drastically changed over the past few
decades. The prevalence of metabolic-associated fatty liver disease (MAFLD) has risen to …

Nonalcoholic fatty liver disease (NAFLD) is related to subclinical atherosclerosis. However,
whether the severity of the disease (or which histopathological component) is associated …

Introduction: Metabolic dysfunction-associated steatotic liver disease (MASLD), previously
known as Nonalcoholic fatty liver disease (NAFLD), is one of the most common hepatic …